XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.19.3

Revenues | 9 Months Ended
--- | ---
Sep. 30, 2019
Revenue From Contract With Customer [Abstract] |
Revenues |
5. | Revenues
Revenues by product. The following table represents total net revenues by product line:
|  | Three Months Ended September 30, | Nine Months Ended September 30,
|  | 2019 |  |  | 2018 |  |  | 2019 |  |  | 2018 |  |
OraQuick® |  | $ | 13,256 |  |  | $ | 12,016 |  |  | $ | 37,813 |  |  | $ | 40,813 |  |
Oragene® |  |  | 11,590 |  |  |  | 22,450 |  |  |  | 27,316 |  |  |  | 52,799 |  |
ORAcollect® |  |  | 2,489 |  |  |  | 1,353 |  |  |  | 9,032 |  |  |  | 3,460 |  |
Intercept® |  |  | 2,230 |  |  |  | 1,743 |  |  |  | 6,144 |  |  |  | 5,811 |  |
Histofreezer® (through August 16, 2019) |  |  | 569 |  |  |  | 2,199 |  |  |  | 5,718 |  |  |  | 6,526 |  |
Other products |  |  | 5,165 |  |  |  | 3,689 |  |  |  | 14,875 |  |  |  | 11,177 |  |
Net product revenues |  |  | 35,299 |  |  |  | 43,450 |  |  |  | 100,898 |  |  |  | 120,586 |  |
Royalty income |  |  | 758 |  |  |  | 1,132 |  |  |  | 2,956 |  |  |  | 4,827 |  |
Research and development funding |  |  | (183 | ) |  |  | 1,083 |  |  |  | 679 |  |  |  | 4,540 |  |
Charitable support reimbursement |  |  | 85 |  |  |  | 220 |  |  |  | 203 |  |  |  | 1,544 |  |
Grant funding |  |  | 30 |  |  |  | - |  |  |  | 201 |  |  |  | - |  |
Other revenues |  |  | 690 |  |  |  | 2,435 |  |  |  | 4,039 |  |  |  | 10,911 |  |
Net revenues |  | $ | 35,989 |  |  | $ | 45,885 |  |  | $ | 104,937 |  |  | $ | 131,497 |  |
Revenues by geographic area. The following table represents total net revenues by geographic area, based on the location of the customer:
|  | Three Months Ended September 30, |  |  |  | Nine Months Ended September 30, |
|  | 2019 |  |  | 2018 |  |  |  | 2019 |  |  | 2018 |
United States |  | $ | 26,245 |  |  | $ | 36,883 |  |  |  | $ | 74,712 |  |  | $ | 99,860 |
Europe |  |  | 2,767 |  |  |  | 1,982 |  |  |  |  | 8,188 |  |  |  | 7,187 |
Other regions |  |  | 6,977 |  |  |  | 7,020 |  |  |  |  | 22,037 |  |  |  | 24,450 |
|  | $ | 35,989 |  |  | $ | 45,885 |  |  |  | $ | 104,937 |  |  | $ | 131,497 |
Customer and Vendor Concentrations. One of our customers accounted for 24% of our accounts receivable as of September 30, 2019. The same customer accounted for approximately 17% and 11% of our net consolidated revenues for the three and nine months ended September 30, 2019 and 39% and 27% of our net consolidated revenues for the three and nine months ended September 30, 2018. We currently purchase certain products and critical components of our products from sole-supply vendors. If these vendors are unable or unwilling to supply the required components and products, we could be subject to increased costs and substantial delays in the delivery of our products to our customers. Also, our subsidiary, DNAG, uses two third-party suppliers to manufacture its product. Our inability to have a timely supply of any of these components and products could have a material adverse effect on our business, as well as our financial condition and results of operations. Deferred Revenue. We record deferred revenue when funds are received prior to the recognition of the associated revenue. Deferred revenue as of September 30, 2019 and December 31, 2018 includes customer prepayments of $2,150 and $2,057, respectively. Deferred revenue as of September 30, 2019 and December 31, 2018 also includes $ 1,790 and $1,464, respectively, associated with a long-term contract that has variable pricing based on volume. The average price over the life of the contract was determined and revenue is recognized at that rate.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI http://asc.fasb.org/topic&trid=49130388 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration